Anixa Biosciences, Inc. (ANIX) vs Milestone Pharmaceuticals Inc. (MIST)
A side-by-side comparison of Anixa Biosciences, Inc. and Milestone Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIX
Anixa Biosciences, Inc.
$3.09HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
MIST
Milestone Pharmaceuticals Inc.
$0.79HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — ANIX vs MIST
growth of $100 · dividends reinvested · last 7yANIX -35.7% (-6.1%/yr)MIST -94.9% (-34.7%/yr)ANIX compounded faster over this window
Log scale — wide-divergence pair
ANIX MIST
ANIX vs MIST: by the numbers
- •ANIX is the larger company ($105M vs $98M market cap).
- •Both run net losses; ANIX's is the smaller (0.00% vs -3585.62% net margin).
Metrics side by side
Valuation
| Metric | ANIX | MIST |
|---|---|---|
| P/S ratio | N/A | 41.75 |
| P/B ratio | 7.25 | 5.37 |
Profitability
| Metric | ANIX | MIST |
|---|---|---|
| Gross margin | 0.00% | 94.58% |
| Operating margin | 0.00% | -4041.72% |
| Net margin | 0.00% | -3585.62% |
| ROE | -72.02% | -461.14% |
| ROIC | -82.35% | -49.27% |
Growth (annualized)
| Metric | ANIX | MIST |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -31.02% |
| Total return CAGR (5Y) | -8.26% | -33.18% |
Frequently asked
- How have ANIX and MIST total returns compared?
- Over the past 5 years, ANIX delivered -8.26% and MIST delivered -33.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.